Ascendis Pharma faces negative sentiment after Novo returned TransCon rights, compounding prior partner exits and pipeline disappointments. Despite pipeline contraction, ASND's approved products—Skytrofa, Yorvipath, and Yuviwel—show robust growth, and Yorvipath net sales should exceed $1.1 billion this year. Yuviwel's strong U.S. launch and favorable BioMarin settlement provide freedom to operate.
The United States is finally starting to dig itself out of a rare earth metals hole it spent decades digging. The effort got a boost on July 29, when Energy Fuels announced that construction has begun on a commercial-scale expansion at its White Mesa Mill in Utah.
Two hundred and fifty years after the signing of the Declaration of Independence, a new commercial from Google asks: What if the Founding Fathers had access to Google Workspace?
| Insurance Industry | Financials Sector | Roy Thung CEO | NYSE Exchange | 453440307 CUSIP |
| US Country | 550 Employees | 14 Feb 2022 Last Dividend | 1 Jul 1996 Last Split | - IPO Date |
Independence Holding Company (IHC) operates through its various subsidiaries in the health, pet, and life insurance sectors, catering to a wide range of insurance needs. Established in 1980 and headquartered in Stamford, Connecticut, IHC boasts an extensive array of products designed for both individuals and businesses. The company effectively combines traditional insurance offerings with modern solutions, ensuring that clients receive comprehensive coverage options. IHC distributes its suite of products through a robust network of general agents, independent brokers, and producers, making it accessible to many consumers across the United States.